Delivery Order SPE2DB25D7067-SPE2DB25FSVZA
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $1,187.44 to AmerisourceBergen Drug Corp for Rocuronium 100 mg/10 mL vials on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order was awarded competitively without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rocuronium is a neuromuscular blocking agent used in surgical and critical care settings,...
- The Defense Logistics Agency awarded a delivery order valued at $1,859.18 to AmerisourceBergen Drug Corp for the supply of Rocuronium 50 mg/5 mL vials on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed price contract represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp for the supply of Rocuronium 100 mg/10 ml vials on August 25, 2025, with completion targeted for August 26, 2025. This competitively awarded contract, issued without set-aside provisions, represents a firm fixed-price transaction for pharmaceutical delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Rocuronium 100 mg/10 ml vials with a ceiling value of $1,105.56. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rocuronium 100 mg/10 mL vials with a ceiling value of $1,228.60. This delivery order, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a firm fixed-price pharmaceutical supply transaction performed in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rocuronium 100 mg/10 mL vials with a ceiling value of $1,346.81. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the qualified vendor. The order is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Rocuronium 100 mg/10 ml vials totaling $1,166.98 under firm fixed pricing. This award represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Rocuronium 100 mg/10 mL vials with a ceiling value of $1,166.98 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 14, 2025, and performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Rocuronium 100 mg/10 mL vials with a ceiling value of $1,166.98 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made on a competitive,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rocuronium 100 mg/10 mL vials. This competitively awarded, non-set-aside contract carries a ceiling value of $1,105.56 and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and holds an...